| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |